Charles Lee

216.2k total citations · 11 hit papers
318 papers, 28.0k citations indexed

About

Charles Lee is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Charles Lee has authored 318 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 104 papers in Genetics and 53 papers in Oncology. Recurrent topics in Charles Lee's work include Genomic variations and chromosomal abnormalities (70 papers), Chromosomal and Genetic Variations (50 papers) and Genomics and Rare Diseases (32 papers). Charles Lee is often cited by papers focused on Genomic variations and chromosomal abnormalities (70 papers), Chromosomal and Genetic Variations (50 papers) and Genomics and Rare Diseases (32 papers). Charles Lee collaborates with scholars based in United States, South Korea and United Kingdom. Charles Lee's co-authors include Stephen W. Scherer, A. John Iafrate, Lars Feuk, Mark A. Rubin, Patricia K. Donahoe, Marc Listewnik, Miguel N. Rivera, Ying Qi, Joëlle Tchinda and Matthew E. Hurles and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Charles Lee

302 papers receiving 27.3k citations

Hit Papers

MET Amplification Leads to Gefitinib Resistance in Lung C... 2004 2026 2011 2018 2007 2005 2004 2007 2005 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
    2007 3.6k citations Jeffrey A. Engelman, Kreshnik Zejnullahu et al. Science profile →
  2. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
    2005 2.8k citations Scott A. Tomlins, Daniel R. Rhodes et al. Science profile →
  3. Detection of large-scale variation in the human genome
    2004 2.1k citations Lars Feuk, Stephen W. Scherer et al. profile →
  4. Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes
    2007 1.3k citations Charles Lee, Stephen W. Scherer et al. Science profile →
  5. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    2005 1.1k citations Mark A. Rubin, Gad Getz et al. profile →
  6. Diet and the evolution of human amylase gene copy number variation
    2007 965 citations Charles Lee et al. profile →
  7. Copy number variation: New insights in genome diversity
    2006 592 citations Lars Feuk, Matthew E. Hurles et al. profile →
  8. Landscape of Somatic Retrotransposition in Human Cancers
    2012 532 citations Ömer Gökçümen, Charles Lee et al. Science profile →
  9. Common deletion polymorphisms in the human genome
    2005 527 citations Charles Lee et al. profile →
  10. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs
    2008 507 citations Charles Lee et al. profile →
  11. Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor
    2024 81 citations Charles Lee, Hansoo Park et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Lee United States 75 14.6k 8.8k 5.9k 5.6k 4.3k 318 28.0k
Michael R. Speicher Germany 64 10.0k 0.7× 4.2k 0.5× 5.7k 1.0× 3.3k 0.6× 6.5k 1.5× 177 19.1k
Richard K. Wilson United States 70 17.7k 1.2× 7.3k 0.8× 5.8k 1.0× 4.8k 0.9× 6.7k 1.5× 221 30.4k
Thomas Ried United States 84 17.7k 1.2× 6.2k 0.7× 7.3k 1.2× 1.9k 0.3× 6.2k 1.4× 378 27.8k
Jerry W. Shay United States 118 35.3k 2.4× 5.2k 0.6× 8.9k 1.5× 3.5k 0.6× 4.9k 1.1× 522 58.0k
Paul S. Meltzer United States 93 22.7k 1.6× 5.3k 0.6× 9.2k 1.6× 5.6k 1.0× 7.2k 1.7× 384 36.0k
D.N. Cooper United Kingdom 90 19.9k 1.4× 10.5k 1.2× 2.1k 0.4× 2.5k 0.4× 3.0k 0.7× 568 34.9k
Olli Kallioniemi Finland 99 20.2k 1.4× 9.4k 1.1× 9.7k 1.7× 7.4k 1.3× 11.3k 2.6× 428 36.3k
Elaine R. Mardis United States 76 24.5k 1.7× 7.1k 0.8× 10.2k 1.7× 5.8k 1.1× 9.8k 2.3× 305 44.2k
Peter Lichter Germany 100 19.4k 1.3× 7.2k 0.8× 6.7k 1.1× 2.7k 0.5× 6.0k 1.4× 490 36.6k
David W. Russell United States 126 29.5k 2.0× 11.2k 1.3× 8.0k 1.4× 2.3k 0.4× 4.7k 1.1× 542 52.6k

Countries citing papers authored by Charles Lee

Since Specialization
Citations

This map shows the geographic impact of Charles Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lee more than expected).

Fields of papers citing papers by Charles Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lee. The network helps show where Charles Lee may publish in the future.

Co-authorship network of co-authors of Charles Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Lee. A scholar is included among the top collaborators of Charles Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Lee. Charles Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Wan‐Ping, Qihui Zhu, Xiaofei Yang, et al.. (2022). JAX-CNV: A Whole-Genome Sequencing-Based Algorithm for Copy Number Detection at Clinical Grade Level. Genomics Proteomics & Bioinformatics. 20(6). 1197–1206. 4 indexed citations
2.
Saitou, Marie, Fuguo Wu, Nancy J. Hall, et al.. (2021). Sex-specific phenotypic effects and evolutionary history of an ancient polymorphic deletion of the human growth hormone receptor. Science Advances. 7(39). eabi4476–eabi4476. 10 indexed citations
3.
Mu, Yongping, et al.. (2019). Molecular mechanisms underlying titanium dioxide nanoparticles (TiO 2 NP) induced autophagy in mesenchymal stem cells (MSC). Journal of Toxicology and Environmental Health. 82(18). 997–1008. 13 indexed citations
4.
Cho, Sung‐Yup, Jeesoo Chae, Deukchae Na, et al.. (2019). Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers. Clinical Cancer Research. 25(9). 2821–2834. 13 indexed citations
5.
Yuki, Koichi, Sophia Koutsogiannaki, Charles Lee, & James A. DiNardo. (2018). Unanticipated hospital admission in pediatric patients with congenital heart disease undergoing ambulatory noncardiac surgical procedures. Pediatric Anesthesia. 28(7). 607–611. 8 indexed citations
6.
Lee, Sanghyuk, et al.. (2018). Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice. Experimental & Molecular Medicine. 50(8). 1–9. 94 indexed citations
7.
Cho, Sung‐Yup, Jee Yun Han, Deukchae Na, et al.. (2017). A Novel Combination Treatment Targeting BCL-XL and MCL1 for KRAS/BRAF -mutated and BCL2L1 -amplified Colorectal Cancers. Molecular Cancer Therapeutics. 16(10). 2178–2190. 12 indexed citations
8.
Zhou, Jun, Kathleen M. Mahoney, Anita Giobbie‐Hurder, et al.. (2017). Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade. Cancer Immunology Research. 5(6). 480–492. 284 indexed citations
9.
Butterfield, Lisa H., Fengmin Zhao, Charles Lee, et al.. (2017). Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697). Clinical Cancer Research. 23(17). 5034–5043. 35 indexed citations
10.
Yu, Lijian, Haesook T. Kim, Siddha Kasar, et al.. (2016). Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation. Clinical Cancer Research. 23(3). 735–745. 62 indexed citations
11.
Slingluff, Craig L., Charles Lee, Fengmin Zhao, et al.. (2013). A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602). Clinical Cancer Research. 19(15). 4228–4238. 90 indexed citations
12.
Park, Hansoo, Seungbok Lee, Hyunjin Kim, et al.. (2012). Comprehensive genomic analyses associate UGT8 variants with musical ability in a Mongolian population. Journal of Medical Genetics. 49(12). 747–752. 41 indexed citations
13.
Setlur, Sunita R., Chen X. Chen, Jung‐Sook Ha, et al.. (2010). Genetic Variation of Genes Involved in Dihydrotestosterone Metabolism and the Risk of Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 19(1). 229–239. 47 indexed citations
14.
Wong, Dominic W. S., et al.. (2010). ORIGINAL RESEARCH: Chromosomal integration of both an α-amylase and a glucoamylase gene in Saccharomyces cerevisiae for starch conversion. Industrial Biotechnology. 6(2). 112–118. 7 indexed citations
15.
Pang, Andy Wing Chun, Jeffrey R. MacDonald, Dalila Pinto, et al.. (2010). Towards a comprehensive structural variation map of an individual human genome. Genome biology. 11(5). R52–R52. 214 indexed citations
16.
Engelman, Jeffrey A., Kreshnik Zejnullahu, Tetsuya Mitsudomi, et al.. (2007). MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling. Science. 316(5827). 1039–1043. 3570 indexed citations breakdown →
17.
Perner, Sven, Francesca Demichelis, Rameen Beroukhim, et al.. (2006). TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer. Cancer Research. 66(17). 8337–8341. 388 indexed citations
18.
Yang, Xinzhen, et al.. (2005). Stoichiometry of Envelope Glycoprotein Trimers in the Entry of Human Immunodeficiency Virus Type 1. Journal of Virology. 79(19). 12132–12147. 134 indexed citations
19.
Tomlins, Scott A., Daniel R. Rhodes, Sven Perner, et al.. (2005). Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. Science. 310(5748). 644–648. 2820 indexed citations breakdown →
20.
Bassing, Craig H., Heikyung Suh, David O. Ferguson, et al.. (2003). Histone H2AX. Cell. 114(3). 359–370. 397 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Speicher Breakdown of academic impact, for papers by Richard K. Wilson Breakdown of academic impact, for papers by Thomas Ried Breakdown of academic impact, for papers by Jerry W. Shay Breakdown of academic impact, for papers by Paul S. Meltzer Breakdown of academic impact, for papers by D.N. Cooper Breakdown of academic impact, for papers by Olli Kallioniemi Breakdown of academic impact, for papers by Elaine R. Mardis Breakdown of academic impact, for papers by Peter Lichter Breakdown of academic impact, for papers by David W. Russell
Rankless by CCL
2026